{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05139238",
            "orgStudyIdInfo": {
                "id": "AAAT5925"
            },
            "organization": {
                "fullName": "Columbia University",
                "class": "OTHER"
            },
            "briefTitle": "Postpartum Hypertension Study",
            "officialTitle": "Oral Nifedipine Versus Intravenous Labetalol for Postpartum (PP) Hypertensive Emergency: A Randomized Clinical Trial (RCT)",
            "therapeuticArea": [
                "Cardiovascular",
                "Other"
            ],
            "study": "postpartum-hypertension-study"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-08",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-01-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-01-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-11-18",
            "studyFirstSubmitQcDate": "2021-11-18",
            "studyFirstPostDateStruct": {
                "date": "2021-12-01",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-15",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-18",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Whitney Booker",
                "investigatorTitle": "Assistant Professor of Obstetrics and Gynecology",
                "investigatorAffiliation": "Columbia University"
            },
            "leadSponsor": {
                "name": "Columbia University",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to assess which blood pressure medication (intravenous labetalol or oral nifedipine) works better in treating severely elevated blood pressure in women who have just delivered a baby.",
            "detailedDescription": "Hypertensive emergencies cause significant maternal morbidity and mortality in the postpartum period. In order to reduced these risks, the recommendation is to treat women with severe range blood pressure with either intravenous labetalol or oral nifedipine; it is unclear which medication is superior. The objective of this study is to prospectively enroll women who have hypertensive emergencies in the postpartum period; women will be randomized in a 1:1 fashion and treated with one of the two antihypertensives to see which one works better."
        },
        "conditionsModule": {
            "conditions": [
                "Postpartum Pregnancy-Induced Hypertension",
                "Postpartum Preeclampsia",
                "Pregnancy-Induced Hypertension in Postpartum",
                "Hypertensive Emergency"
            ],
            "keywords": [
                "Hypertension",
                "Hypertensive Emergency",
                "Postpartum",
                "Preeclampsia"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 104,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Oral Nifedipine",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Oral nifedipine: Once diagnosis of hypertensive emergency is confirmed on repeat blood pressure, patients randomized to oral nifedipine will receive 10mg initially, with repeated doses of 20mg every 20min, for up to a maximum of 5 doses or until the therapeutic blood pressure goal of \\<160 systolic and \\<105 diastolic is achieved. If the therapeutic goal is not achieved after 5 doses, crossover to the alternative study medication will occur.",
                    "interventionNames": [
                        "Drug: Nifedipine"
                    ]
                },
                {
                    "label": "Intravenous labetalol",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Intravenous Labetalol: Patients randomized to IV labetalol will receive 20mg initially, followed by escalating doses of 40mg, 80mg, 80mg, then 80mg every 20 minutes until the therapeutic goal is achieved, for a maximum of 5 doses. If the therapeutic goal is not achieved after 5 doses, crossover to the alternative study medication will occur.",
                    "interventionNames": [
                        "Drug: Labetalol"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Labetalol",
                    "description": "Intravenous labetalol, a short acting ant-hypertensive",
                    "armGroupLabels": [
                        "Intravenous labetalol"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Nifedipine",
                    "description": "Oral nifedipine, a short acting ant-hypertensive",
                    "armGroupLabels": [
                        "Oral Nifedipine"
                    ],
                    "otherNames": [
                        "Oral Procardia"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Average Time to Initial Blood Pressure Control (minutes)",
                    "description": "The primary outcome will be time (minutes) interval required to achieve the therapeutic BP goal of \\<160 mmHg systolic and \\<110 mmHg diastolic.",
                    "timeFrame": "Up to 48 hours"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Average Number of Recurrence of Severe Blood Pressure",
                    "description": "The number of times a patient has recurrence of severe hypertensive necessitating treatment with an antihypertensive.",
                    "timeFrame": "Up to 48 hours"
                },
                {
                    "measure": "Total Number of Participants Who Need for Second Antihypertensive Agent",
                    "description": "The need to use a second (alternative) antihypertensive medication.",
                    "timeFrame": "Up to 48 hours"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion criteria\n\n* Patients admitted to labor and delivery (L\\&D) with blood pressure (BP) in severe range, defined as a systolic \u2265160 mm Hg and/or diastolic \u2265110 mm Hg\n* Postpartum, immediately to 6 weeks postpartum\n* With a prior diagnosis of chronic hypertension (not on medication) or hypertensive disorder of pregnancy\n\nExclusion criteria\n\n* They may not have previously had exposure to either study medication within the previous 24-hour period.\n* Patients with a known atrial-ventricular heart block or moderate to severe bronchial asthma will be excluded, or other contraindication to receiving either study medication",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Whitney A. Booker, MD",
                    "role": "CONTACT",
                    "phone": "212-305-7334",
                    "email": "wb2322@cumc.columbia.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Whitney A. Booker, MD",
                    "affiliation": "Columbia University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Columbia University Irving Medical Center",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10032",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Whitney A. Booker, MD",
                            "role": "CONTACT",
                            "phone": "212-305-7334",
                            "email": "wb2322@cumc.columbia.edu"
                        },
                        {
                            "name": "Whitney A. Booker, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "UNDECIDED"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011225",
                    "term": "Pre-Eclampsia"
                },
                {
                    "id": "D000046110",
                    "term": "Hypertension, Pregnancy-Induced"
                },
                {
                    "id": "D000006973",
                    "term": "Hypertension"
                },
                {
                    "id": "D000096003",
                    "term": "Hypertensive Crisis"
                },
                {
                    "id": "D000006974",
                    "term": "Hypertension, Malignant"
                },
                {
                    "id": "D000004630",
                    "term": "Emergencies"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000011248",
                    "term": "Pregnancy Complications"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10024",
                    "name": "Hypertension",
                    "asFound": "Hypertension",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7796",
                    "name": "Emergencies",
                    "asFound": "Emergency",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14106",
                    "name": "Pre-Eclampsia",
                    "asFound": "Preeclampsia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M25635",
                    "name": "Hypertension, Pregnancy-Induced",
                    "asFound": "Pregnancy Induced Hypertension",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7633",
                    "name": "Eclampsia",
                    "relevance": "LOW"
                },
                {
                    "id": "M3202",
                    "name": "Hypertensive Crisis",
                    "asFound": "Hypertensive Emergency",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10025",
                    "name": "Hypertension, Malignant",
                    "asFound": "Hypertensive Emergency",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "T2019",
                    "name": "Eclampsia",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007741",
                    "term": "Labetalol"
                },
                {
                    "id": "D000009543",
                    "term": "Nifedipine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002121",
                    "term": "Calcium Channel Blockers"
                },
                {
                    "id": "D000049990",
                    "term": "Membrane Transport Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000077264",
                    "term": "Calcium-Regulating Hormones and Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000014665",
                    "term": "Vasodilator Agents"
                },
                {
                    "id": "D000015149",
                    "term": "Tocolytic Agents"
                },
                {
                    "id": "D000012102",
                    "term": "Reproductive Control Agents"
                },
                {
                    "id": "D000000319",
                    "term": "Adrenergic beta-Antagonists"
                },
                {
                    "id": "D000018674",
                    "term": "Adrenergic Antagonists"
                },
                {
                    "id": "D000018663",
                    "term": "Adrenergic Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000000959",
                    "term": "Antihypertensive Agents"
                },
                {
                    "id": "D000013566",
                    "term": "Sympathomimetics"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000058668",
                    "term": "Adrenergic alpha-1 Receptor Antagonists"
                },
                {
                    "id": "D000000317",
                    "term": "Adrenergic alpha-Antagonists"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10761",
                    "name": "Labetalol",
                    "asFound": "Deep breathing",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12483",
                    "name": "Nifedipine",
                    "asFound": "Marginal zone",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5384",
                    "name": "Calcium Channel Blockers",
                    "relevance": "LOW"
                },
                {
                    "id": "M5381",
                    "name": "Calcium",
                    "relevance": "LOW"
                },
                {
                    "id": "M5398",
                    "name": "Calcium, Dietary",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M17412",
                    "name": "Vasodilator Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M17869",
                    "name": "Tocolytic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M3671",
                    "name": "Adrenergic beta-Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20746",
                    "name": "Adrenergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20755",
                    "name": "Adrenergic Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4277",
                    "name": "Antihypertensive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M16345",
                    "name": "Sympathomimetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M29194",
                    "name": "Adrenergic alpha-1 Receptor Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M3669",
                    "name": "Adrenergic alpha-Antagonists",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "AnAg",
                    "name": "Antihypertensive Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "ChanBlk",
                    "name": "Channel Blockers"
                },
                {
                    "abbrev": "VaDiAg",
                    "name": "Vasodilator Agents"
                },
                {
                    "abbrev": "Repr",
                    "name": "Reproductive Control Agents"
                },
                {
                    "abbrev": "BDCA",
                    "name": "Bone Density Conservation Agents"
                }
            ]
        }
    },
    "hasResults": false
}